Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103
Julie Davies, Jing Chen, Ryan Pink, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy
Molly J. Sullan, Breton M. Asken, Michael S. Jaffee, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 84, pp. 316-324
Closed Access | Times Cited: 107
Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease
Xinyi Chen, Yifeng Du, Lei Chen
Frontiers in Molecular Neuroscience (2019) Vol. 11
Open Access | Times Cited: 99
Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
Ali Seifinejad, Mergim Ramosaj, Ling Shan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 19
Open Access | Times Cited: 32
Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer’s disease-risk genes
Zhixiong Ma, Weiliang Jiang, Eric Erquan Zhang
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 71
Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Orexin and Alzheimer’s Disease
Claudio Liguori
Current topics in behavioral neurosciences (2016), pp. 305-322
Open Access | Times Cited: 63
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects
Ricardo S. Osorio, Emma L. Ducca, Margaret Wohlleber, et al.
SLEEP (2016) Vol. 39, Iss. 6, pp. 1253-1260
Open Access | Times Cited: 56
Orexin‐A increases the firing activity of hippocampal CA1 neurons through orexin‐1 receptors
Xinyi Chen, Lei Chen, Yifeng Du
Journal of Neuroscience Research (2016) Vol. 95, Iss. 7, pp. 1415-1426
Closed Access | Times Cited: 54
Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK/ERK/mTOR pathway
Dandan Xu, Tingting Kong, Shengnan Zhang, et al.
Cellular Signalling (2020) Vol. 79, pp. 109839-109839
Open Access | Times Cited: 40
The interaction between orexin, sleep deprivation and Alzheimer’s disease: Unveiling an Emerging Connection
Masoumeh Kourosh‐Arami, Mahdi Ramezani, Alireza Komaki‬
The Journal of Physiological Sciences (2025) Vol. 75, Iss. 1, pp. 100004-100004
Open Access
Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E ε4
Shin Gyeom Kim, Musung Keum, Young Min Choe, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 595-595
Open Access
Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
Chao Zhuang, Hengyu Yan, Jiayu Lu, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
The Arg–Phe‐amide peptide 26RFa/glutamine RF‐amide peptide and its receptor: IUPHAR Review 24
Jérôme Leprince, Didier Bagnol, Ronan Bureau, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 20, pp. 3573-3607
Open Access | Times Cited: 46
Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease
Stéphane Peineau, Kevin Rabiant, Olivier Pierrefiche, et al.
Pharmacological Research (2018) Vol. 130, pp. 385-401
Closed Access | Times Cited: 46
The Neuropeptide 26RFa (QRFP) and Its Role in the Regulation of Energy Homeostasis: A Mini-Review
Nicolas Chartrel, Marie Picot, Mouna El Medhi, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 42
Iron Oxide Nanoparticle Delivery of Peptides to the Brain: Reversal of Anxiety during Drug Withdrawal
Nathan J. Vinzant, Jamie L. Scholl, Chia-Ming Wu, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 40
Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches
Kiran Kumar Siddappaji, Shubha Gopal
AIMS neuroscience (2021) Vol. 8, Iss. 3, pp. 357-389
Open Access | Times Cited: 27
Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Yu-Ying Sun, Zhun Wang, He-Yan Zhou, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 10, pp. 1467-1478
Closed Access | Times Cited: 19
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui� Zhang, David A. Perrey, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8806-8825
Open Access | Times Cited: 23
Hippocampal orexin receptors: Localization and function
Mahmoud Elahdadi Salmani, Masoumeh Sarfi, Iran Goudarzi
Vitamins and hormones (2022), pp. 393-421
Closed Access | Times Cited: 17
Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients
Takayuki Kondo, Norikazu Hara, Satoshi Koyama, et al.
Nature Aging (2022) Vol. 2, Iss. 2, pp. 125-139
Closed Access | Times Cited: 16
Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors
Maria Jäntti, Ilona Mandrika, Jyrki P. Kukkonen
Biochemical and Biophysical Research Communications (2014) Vol. 445, Iss. 2, pp. 486-490
Closed Access | Times Cited: 33
Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gαs–cAMP-cAMP Response Element Binding Protein Signaling Pathway in Vitro
Qingjie Xue, Bo Bai, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 30
Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction
Coleman B. Calva, Jim R. Fadel
Brain Research (2018) Vol. 1731, pp. 145921-145921
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top